Vinge advises Active Biotech on rights offering

Vinge advises Borgo in connection with its inaugural issuance of primary capital instruments (AT1)

Vinge has advised Borgo AB (publ) in connection with its successful issuance of primary capital instruments (so called “AT1 bonds”) in the amount of SEK 350 million with a floating rate coupon of 3-month STIBOR + 390 basis points.

Vinge advises J Bil in conjunction with the acquisition of Appelskog Bil AB

Vinge has advised the buyer J Bil AB in conjunction with the acquisition of all shares in Appelskog Bil AB.

Vinge has advised United Lithium Corp. in connection with the acquisition of Swedish Minerals AB

United Lithium is an exploration & development company focused on the global demand for lithium, uranium and rare earth elements.